- Home
- REPL vs CCBG Comparison
REPL vs CCBG Comparison
Compare REPL & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REPL | CCBG |
|---|---|---|
| Founded | 2015 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.3M | 726.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | REPL | CCBG |
|---|---|---|
| Price | $9.93 | $42.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $12.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.6M | 64.1K |
| Earning Date | 02-11-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | N/A | ★ 17.47 |
| EPS | N/A | ★ 3.57 |
| Revenue | N/A | ★ $246,433,000.00 |
| Revenue This Year | N/A | $12.46 |
| Revenue Next Year | N/A | $3.24 |
| P/E Ratio | ★ N/A | $11.91 |
| Revenue Growth | N/A | ★ 9.03 |
| 52 Week Low | $2.68 | $32.38 |
| 52 Week High | $14.80 | $45.63 |
Technical Indicators
Market Signals| Indicator | REPL | CCBG |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 45.39 |
| Support Level | $9.70 | $42.15 |
| Resistance Level | $10.27 | $42.97 |
| Average True Range (ATR) | 0.38 | 0.92 |
| MACD | -0.08 | -0.30 |
| Stochastic Oscillator | 55.35 | 5.46 |
Price Performance
Historical ComparisonAbout REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.